1 of 3
Daiichi Life Bids Challenger
- Daiichi Life, via TAL Daiichi Life Australia, offered to purchase Challenger’s remaining 79.5% shareholding.
- The offer values Challenger at AU$7.94 billion, pricing shares at AU$11.80 each, a 19.8% premium.
- Challenger’s shares jumped up to 18% in Sydney, while Daiichi Life’s Tokyo stock rose about 1%.
- If completed, Daiichi would control Australia’s largest annuities provider, adding to its ¥1.5 trillion strategic-investment plan through March 2031.
1 / 3
